Most Recent
Former Labor MP, now workplace umpire not DQ’d from ‘same pay’ cases: court
A judge has dismissed a bid by a group of labour hire companies to disqualify former Labor MP now Fair Work Commission deputy president Terri Butler from same job, same pay cases for apprehended bias.
Apple, Google engaged in anti-competitive conduct, says judge
In a major win for two class actions and Fortnite maker Epic Games, a judge has found that Apple and Google misused their market power in running app stores and in-app purchase systems.
Construction PRO
Santos wins $690M against Fluor over Gladstone LNG project
Energy giant Santos has won a dispute over its Gladstone LNG project, described by a court as "litigation on a monumental scale", securing a $692 million judgment against engineering firm Fluor with the help of four silks.
Trial over Cosette’s termination of $672M Mayne Pharma merger delayed
Mayne Pharma and US drug maker Cosette have agreed to postpone the start of trial in a case over the termination of a $672 million merger to allow for late amendments.
Gilbert + Tobin’s head of corporate advisory to join Corrs Chambers Westgarth
Gilbert +Tobin’s executive partner and corporate advisory head Tim Gordon will join Corrs Chambers Westgarth’s corporate practice based after almost 20 years at G+T.
New Aim appeals trade secrets loss over employee’s WeChat contacts
E-commerce merchandise importer New Aim is challenging the dismissal of its trade secrets case against a former employee, who gave the contact details of the company's suppliers to a competitor after jumping ship.
High Court shoots down solicitors’ CFO in Blue Sky class action
The High Court has unanimously found the Federal Court has no power to allow solicitors to take a cut of a settlement or judgment in a shareholder class action against Blue Sky, saying it would be contrary to rules against contingency fees in NSW. 
Mayne denies continuous disclosure breaches in feud with Cosette
Mayne Pharma has denied US drug maker Cosette's claims it breached its continuous disclosure obligations in relation to US FDA concerns about marketing for its Nextstellis contraceptive, as the drug makers spar over their $672 million merger.
Mayne Pharma may face disclosure breach claim over $672M merger collapse
A court has heard US drug maker Cosette may amend its case to accuse Adelaide's Mayne Pharma of continuous disclosure breaches in their battle over the termination of their $672 million merger.
Construction PRO
Charter Hall can respond to Pitt St developer’s reply evidence in $100M suit
A judge has allowed Charter Hall to respond to developer Pro-Invest’s expert evidence in a case claiming $100 million in damages for the lost opportunity to build a 26-storey hotel in the Sydney CBD.